Peri-infarct ischaemia assessed by cardiovascular MRI: comparison with quantitative perfusion single photon emission

E Gerbaud1, H Cochet, E Bullier

  • 11 Soins Intensifs Cardiologiques, Plateau de Cardiologie Interventionnelle, CHU de Bordeaux, Hôpital du Haut Lévêque, Pessac, France.

Abstract

Insights

Cardiac MRI (CMR) can quantify peri-infarct ischemia by fusing perfusion and delayed-enhancement images. This new method shows excellent agreement with SPECT imaging, offering potential for improved ischemia assessment.

Area of Science:

  • Cardiovascular Imaging
  • Medical Physics
  • Radiology

Background:

  • Peri-infarct ischemia assessment is crucial for managing myocardial infarction.
  • Current methods like SPECT have limitations in precise quantification.
  • Cardiac Magnetic Resonance (CMR) offers advanced imaging capabilities for myocardial assessment.

Purpose of the Study:

  • To develop and evaluate a novel CMR method for quantifying peri-infarct ischemia.
  • To fuse perfusion and delayed-enhanced CMR images for improved accuracy.
  • To validate the CMR method against quantitative single-photon emission CT (SPECT) imaging.

Main Methods:

  • Forty patients with peri-infarct ischemia on SPECT were recruited.
  • Myocardial perfusion was assessed using stress adenosine CMR.
  • Peri-infarct ischemia quantified by fused CMR images was compared to SPECT-derived metrics (SD% and TPD).

Main Results:

  • Excellent agreement was found between CMR-quantified peri-infarct ischemia and SPECT measures (ICC=0.969 for SD%, ICC=0.877 for TPD).
  • CMR demonstrated high diagnostic performance for detecting significant coronary artery stenosis (AUC=0.856).
  • The optimal cut-off of 8.1% for CMR-defined ischemia yielded 96% specificity and 97% positive predictive value.

Conclusions:

  • CMR imaging, using fused perfusion and delayed-enhancement, shows potential for accurate peri-infarct ischemia quantification.
  • This technique validates the intuitive approach of subtracting scar from perfusion defects.
  • The findings support CMR as a valuable tool in the assessment of ischemic heart disease.